Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Choyke Website

Peter L. Choyke, M.D., F.A.C.R.

Gallery Pictures

Labeled Dendritic Cell Tracking
Labeled Dendritic Cell Tracking
15 min after the injection of radiolabeled dendritic cells, activity can be seen in the lungs of a mouse
Labeled Dendritic Cell tracking
Labeled Dendritic Cell tracking
6 hours after injection of radiolabeled dendritic cells the activity has begun to migrate from the lungs to the liver
Labeled dendritic cell labeling
Labeled dendritic cell labeling
2 days after the injection of radiolabeled dendritic cells most of the activity is in the liver, spleen and nodes
Prostate Cancer on MRI
Prostate Cancer on MRI
T2 weighted scan of a patient suspected of prostate cancer reveals a right sided peripheral zone lesion.
Prostate Cancer on MRI
Prostate Cancer on MRI
Apparent Diffusion Coefficient map of the same patient showing low signal in the same area of abnormality as the T2 weighted scan. Subsequent MRI-US fusion biopsy revealed a cancer at this site that was resected
Fluoroestradiol (FES) PET scan before treatment
Fluoroestradiol (FES) PET scan before treatment
FES PET scan demonstrates intense liver and bowel activity but also multiple bone metastases in this patient with breast cancer
FES PET Scan after treatment with endoxifen
FES PET Scan after treatment with endoxifen
Post treatment FES PET scan demonstrates no activity in the bone lesions.
F18 VM4 (CA IX) PET in Renal cancer
F18 VM4 (CA IX) PET in Renal cancer
This patient received an experimental PET agent, F18-VM4 that targets the CAIX enzyme. Metastatic lesions in the lung demonstrate increased activity. Normal liver and kidney activity is seen.
F18 Albumen
F18 Albumen
This is a blood pool PET agent used for determining blood volumes within tumors non-invasively.

This page was last updated on 5/30/2014.